In the BioHarmony Drug Report Database

"Preview" Icon

Sevelamer

Renagel (sevelamer) is a small molecule pharmaceutical. Sevelamer was first approved as Renagel on 1998-10-30. It is used to treat hyperphosphatemia in the USA. It has been approved in Europe to treat hyperphosphatemia and renal dialysis.

 

Trade Name

 

Renagel
 

Common Name

 

sevelamer
 

ChEMBL ID

 

CHEMBL1201798
 

Indication

 

hyperphosphatemia, renal dialysis
 

Drug Class

 

Polymers

Image (chem structure or protein)

Sevelamer structure rendering